Skip to main content
. 2018 Aug 10;10:498–508. doi: 10.1016/j.dadm.2018.07.006

Table 3.

Demographics and clinical characteristics of survey and interview participants

Characteristic Survey participants, N = 100 (%) Interview participants, N = 15 (%)
Age (years)
 Mean (SD) [range] 77 (±7) [65–96] 76 [66–88]
Gender
 Male 49 (49) 7 (47)
 Female 50 (50) 8 (53)
 Prefer not to say 1 (1) 0
Ethnicity
 Caucasian/White 71 (71) 11 (73)
 Black/African American 21 (21) 3 (20)
 Other/Mixed/Multiethnic 4 (4) 1 (7)
 Hawaiian/Pacific Islander 3 (3) 0
 Hispanic 1 (1) 0
Living situation
 Living with spouse/partner 58 (58) 9 (60)
 Living alone 26 (26) 3 (20)
 Living with family 15 (15) 3 (20)
 Living in sheltered accommodation 1 (1) 0
Time since symptom onset
 <6 months 7 (7) 2 (13)
 6 months–1 year 14 (14) 4 (27)
 1–2 years 38 (38) 3 (20)
 3–4 years 18 (18) 3 (20)
 5–10 years 8 (8) 3 (20)
 >10 years 10 (10) 0
 Unknown 5 (5) 0
Age at diagnosis
 Known 72 (72) 10 (67)
 Mean age in years (SD) [range] 75 (±7) [63–94] 74 [66–86]
 Unknown 17 (17) 2 (13)
 Suspected—no yet confirmed 11 (11) 3 (20)
Medication usage
 Currently receiving medication 46 (46) 7 (47)
 Mean months on medication (SD) [range] 25 (±30) [0–153] 38 [3–98]
 Not currently receiving medication 54 (54) 8 (53)
 Of which, previously received medication 3 (6) 1 (13)

Abbreviation: SD, standard deviation.